GOSS

Neutral

Gossamer Bio (NASDAQ: GOSS) extends early tender deadline in major convertible note exchange

Gossamer Bio (NASDAQ: GOSS) has extended the early tender deadline for its exchange offer and consent solicitation for its 5.00% Convertible Senior No...

Stock Titan Yesterday 0

Bearish

GOSS STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Gossamer Bio, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!

Bronstein, Gewirtz and Grossman, LLC has announced a class action lawsuit against Gossamer Bio, Inc. (NASDAQ:GOSS) and some of its officers. The lawsu...

ACCESS Newswire 2 weeks ago 0

Bearish

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Gossamer Bio, Inc. of Class Action Lawsuit and Upcoming Deadlines - GOSS

Pomerantz LLP has announced a class action lawsuit against Gossamer Bio, Inc. (NASDAQ: GOSS) following a significant drop in its stock price. This leg...

PR Newswire 2 weeks ago 0